Jayanth Sridhar
Ophthalmology · Miami, FLNPI 1366746166
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $333,757 of the $525,131 with a category attached, or 63.6%. 18 manufacturers reported payments, led by Regeneron Healthcare Solutions, Inc. at 58.8% of the total. Among ophthalmology clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 420 payments — averaging $1250.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron Healthcare Solutions, Inc.$309K
- Genentech USA, Inc.$82K
- Alcon$68K
- Apellis Pharmaceuticals, Inc.$22K
- Astellas Pharma US Inc$10K
- Eyepoint US, Inc.$8K
- plus $27K from 12 others
What the payments were for
- Consulting fees$137,92626%
- Speaking & faculty fees$333,75764%
- Travel & lodging$44,5098%
- Food & beverage$8,9402%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 216 | $308,730 |
| Genentech USA, Inc. | 75 | $82,136 |
| Alcon | 52 | $67,580 |
| Apellis Pharmaceuticals, Inc. | 20 | $21,511 |
| Astellas Pharma US Inc | 6 | $10,261 |
| Eyepoint US, Inc. | 6 | $8,130 |
| AbbVie(2 entities) | 15 | $7,476 |
| Regeneron | 8 | $7,291 |
| Alcon Research LLC | 4 | $4,900 |
| Dutch Ophthalmic, USA | 3 | $4,546 |
| Ocular Therapeutix, Inc. | 1 | $1,500 |
| Thrombogenics, Inc. | 2 | $557 |
| Carl Zeiss Meditec, Inc. | 3 | $182 |
| Novartis | 3 | $145 |
| Alimera Sciences, Inc. | 2 | $104 |
| Bausch & Lomb Americas Inc. | 2 | $44 |
| Genentech, Inc. | 1 | $22 |
| Biotissue Holdings Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EYLEA HD$202,190
- EYLEA$111,690
- VABYSMO$71,414
- Constellation$48,992
- NGENUITY$24,485
- FINESSE SHARKSKIN$12,802
- Alcon Greishaber Finesse$11,881
- Luxor$11,378
- YUTIQ$7,306
- OZURDEX$7,079
- Lucentis$5,505
- EVA Ophthalmic Surgical System$4,500
- SUSVIMO$4,335
- Unity$1,500
- EYP-1901$825
- Jetrea$500
How this compares
$525,131 in reported general payments places this provider in the 95th percentile of 1,405 ophthalmology providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 14 | $796 |
| Latanoprost | 26 | $181 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 17 | $140 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Miami
- William TrattlerMiami$579K
- Jennifer LohMiami$545K
- Kendall DonaldsonMiami$349K
- Jaclyn KovachMiami$333K
- Andrew SchimelMiami$320K
- Carlos BuznegoMiami$287K
- Felipe MedeirosMiami$266K
- Michael YimMiami$161K
- Arnulfo MansurMiami$134K
- Basil WilliamsMiami$94K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.